Niowave has entered into a new agreement with Novartis to supply Actinium-225, a highly promising medical isotope The long-term supply agreement supports the development of next-generation therapies ...
NEW YORK, March 24, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it has entered into ...
BELLEVUE, Wash.--(BUSINESS WIRE)--TerraPower Isotopes announced today it is producing actinium-225 1 at commercial-scale, providing sustained access to highly pure actinium-225 to the global ...
DUBLIN, Ohio, April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for ...
$450 million East Coast flagship cGMP facility will increase Ac-225 production capacity twentyfold, supporting the next generation of cancer therapies PHILADELPHIA, May 6, 2026 /PRNewswire/ -- ...
Hosted on MSN
Why is Actinium Pharmaceuticals stock rising today?
Actinium Pharmaceuticals, Inc. (ATNM) stock was in the spotlight on Friday after the company announced promising new preclinical findings for its novel radiotherapy, ATNM-400, at the 2025 San Antonio ...
The MarketWatch News Department was not involved in the creation of this content. -- Niowave has entered into a new agreement with Novartis to supply Actinium-225, a highly promising medical isotope - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results